Capewell S, Wathen C G, Hannan W J, Muir A L
Department of Medicine, Royal Infirmary, Edinburgh, UK.
Eur J Clin Pharmacol. 1990;39(6):539-43. doi: 10.1007/BF00316091.
Sixteen patients with previously untreated mild/moderate hypertension (WHO Stage I) were studied: 7 women and 9 men, mean age 56.2 y. Haemodynamics, central and pulmonary blood volumes were measured by radionuclide techniques and repeated after 8 weeks felodipine therapy. To achieve a target diastolic blood pressure of less than 95 mm Hg 12 patients required 5 mg bid, 2 10 mg bid and 1 2.5 mg bid; 1 withdrew after 2 weeks. Mean (SD) arterial blood pressure (mm Hg) was 189/106 before, and 182/103 after 2 weeks placebo treatment and fell to 148/84 after 8 weeks felodipine therapy. Relative systemic vascular resistance fell by 19% from 2146 to 1734 dyn.s.cm-5. There were no significant changes in heart rate, cardiac index, total blood volume, pulmonary blood volume or left ventricular ejection fraction. Plasma renin activity did not rise significantly. Short lived vasodilator side effects occurred in 7/16 patients during initial treatment and mild ankle oedema persisted in 4/16 patients. In contrast to the haemodynamic changes seen acutely with felodipine, the only sustained changes after 8 weeks therapy are reductions in systemic vascular resistance and blood pressure.
对16例未经治疗的轻度/中度高血压(WHO I期)患者进行了研究:7名女性和9名男性,平均年龄56.2岁。采用放射性核素技术测量血流动力学、中心血容量和肺血容量,并在非洛地平治疗8周后重复测量。为使舒张压目标值低于95 mmHg,12例患者需要每日两次服用5 mg,2例每日两次服用10 mg,1例每日两次服用2.5 mg;1例在2周后退出。安慰剂治疗2周前平均(标准差)动脉血压(mmHg)为189/106,治疗后为182/103,非洛地平治疗8周后降至148/84。相对体循环血管阻力从2146 dyn.s.cm-5降至1734 dyn.s.cm-5,下降了19%。心率、心脏指数、总血容量、肺血容量或左心室射血分数无显著变化。血浆肾素活性未显著升高。7/16的患者在初始治疗期间出现短暂的血管舒张副作用,4/16的患者持续存在轻度踝部水肿。与非洛地平急性观察到的血流动力学变化相反,治疗8周后唯一持续的变化是体循环血管阻力和血压降低。